Spore.Bio Secures $23M Series A for Groundbreaking Microbiology Innovation

Deal News | Feb 20, 2025 | Localglobe

Spore.Bio Secures $23M Series A for Groundbreaking Microbiology Innovation

Spore.Bio, an innovative microbiology company, has secured $23 million in Series A funding, led by Localglobe. This funding is set to advance Spore.Bio’s groundbreaking microbiology testing technology, which utilizes light-power to deliver accurate insights within minutes, significantly faster than traditional methods. This technology holds promise for improving safety across various industries by potentially saving lives through rapid microbiological assessments. The company’s achievements include a partnership with the renowned Pasteur Institute and the acquisition of a local competitor, and it already has over 200 factories prepared to implement its technology. Spore.Bio aims to make a lasting impact on global food safety and public health. Alongside founders Amine Raji, Maxime Mistretta, and Mohamed Tazi, the company welcomes the involvement of the Singular team led by Raffi and Maud as it continues its mission to transform the microbiology landscape. This development marks a significant contribution to the European and global microbiology communities.

Sectors

  • Biotechnology
  • Food Safety
  • Venture Capital

Geography

  • France – Spore.Bio is partnering with the Pasteur Institute, a significant player in the French microbiology community.
  • Europe – The funding and operations have a substantial impact on the European microbiology sector.

Industry

  • Biotechnology – Spore.Bio operates in the biotechnology industry, specializing in microbiology testing using innovative technologies.
  • Food Safety – The company's technology is poised to transform food safety standards by delivering rapid and accurate microbiological insights.
  • Venture Capital – Localglobe, a venture capital firm, has provided funding, highlighting the role of VC in early-stage innovative biotech companies.

Financials

  • $23,000,000 – Series A funding amount secured by Spore.Bio.

Participants

NameRoleTypeDescription
Spore.BioTarget CompanyCompanyA pioneering biotech firm focusing on light-powered microbiology testing.
LocalglobeInvestorCompanyA venture capital firm providing Series A funding for Spore.Bio.
Pasteur InstitutePartnerCompanyA world-leading microbiology research institute partnering with Spore.Bio.
SingularCollaborative PartnerCompanyJoining the journey with Spore.Bio to support its mission.
Amine RajiFounderPersonCo-founder of Spore.Bio, contributing to its innovative technology and mission.
Maxime MistrettaFounderPersonCo-founder of Spore.Bio, contributing to its innovative technology and mission.
Mohamed TaziFounderPersonCo-founder of Spore.Bio, contributing to its innovative technology and mission.